X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Translational Cancer Research

期刊標題檢索 TRANSL CANCER R 最新評論: I applied on March 30th and I have been at step 4 ever since (2024-05-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Translational Cancer Research]您好,您是該頁面的第 67118 位訪客。

期刊簡介
期刊名稱Translational Cancer Research Translational Cancer Research
LetPub Score
5.3
50 ratings
Rate

Reputation
6.4

Influence
3.9

Speed
7.1

期刊簡稱TRANSL CANCER RES
ISSN2218-676X
E-ISSN2219-6803
h-index22
CiteScore
CiteScoreSJRSNIPCiteScore Rank
2.100.4220.390
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q3209 / 333
Category: Medicine
Subcategory: Oncology
Q3271 / 404
Category: Medicine
Subcategory: Cancer Research
Q4183 / 230

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
官方網站http://tcr.amegroups.com/
在線稿件提交http://tcr.amegroups.com/login?source=%2Fauthor%2Fsubmit
開放訪問No
出版商AME Publishing Company
主題領域ONCOLOGY
出版國/地區PEOPLES R CHINA
發行頻率
創刊年0
每年文章數261每年文章數趨勢
黃金OA百分比99.74%
Web of Science 四分位
2023-2024
WOS Quartile: Q4

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ4259/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2218-676X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Translational Cancer Research】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640780
    BIOMATERIALS569987
    BIOMEDICINE & PHARMACOTHERAPY498335
    Frontiers in Pharmacology486697
    JOURNAL OF ETHNOPHARMACOLOGY477132
    Journal of Materials Chemistry B476057
    Frontiers in Immunology457902
    COLLOIDS AND SURFACES B-BIOINTERFACES419218
    COMPUTERS IN BIOLOGY AND MEDICINE416329
    Frontiers in Oncology413408
  •  

    Translational Cancer Research Translational Cancer Research
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/22)
  [Translational Cancer Research] 的評論撰寫評論
作者: 靖烟少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-29 15:19:11 評論於
I applied on March 30th and I have been at step 4 ever since
(0) 讚! | 靖烟少爷

作者: 橙子GO


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-23 15:29:17 評論於
May I ask what the current result is? Have I been hired?
(0) 讚! | 橙子GO

作者: amyi


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-18 09:28:58 評論於
The relationship is still good, I communicated with the editor, and got accepted in three months
(0) 讚! | amyi

作者: 伏象小烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-13 14:49:15 評論於
同问
Can you translate the following paragraph into English and Japanese and title each translation with ":" and ":"?
(0) 讚! | 伏象小烟

作者: 伏象小烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-10 22:15:27 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as the titles:

同问!
(0) 讚! | 伏象小烟

作者: 伏象小烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-10 16:54:33 評論於
Will I receive a receipt letter from the magazine publisher after making the payment?
(0) 讚! | 伏象小烟

作者: 伏象小烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-10 16:49:10 評論於
Did you receive a confirmation email after submitting the payment screenshot as requested? I have not received one
(0) 讚! | 伏象小烟

作者: 墟散剑博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 21:44:38 評論於
How are you doing, brother?
(0) 讚! | 墟散剑博

作者: 伏象小烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 12:14:27 評論於
Accepted
(0) 讚! | 伏象小烟

作者: 是你的宏盛呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-21 14:32:32 評論於
My second round of peer review has been over 2 months, feeling anxious about graduation
(0) 讚! | 是你的宏盛呀

作者: 伏象小烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 11:08:04 評論於
I'm not sure, I've been here fixing it all along
(0) 讚! | 伏象小烟

作者: 伏象小烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 09:30:13 評論於
I am also in STEP 5 after the major overhaul, it has been 20 days and no news, should I send an email?
(0) 讚! | 伏象小烟

作者: 东京绮烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-11 19:10:03 評論於
Received a sudden notification from Xiaoxiu today, so excited
(0) 讚! | 东京绮烟

作者: 伏象小烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-11 08:28:40 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0 Overemphasized research direction: tumor experience sharing: Stayed at step 5 for 20 days after major revision, no news, what should I do?
(0) 讚! | 伏象小烟

作者: 东京绮烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-10 10:24:26 評論於
I have been at step 4 since submitting my manuscript, and I have not received any feedback from the reviewers yet
(0) 讚! | 东京绮烟

作者: 赫莫萨西尼尔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-09 15:19:05 評論於
Have you been staying at Step 4 ever since the major renovation?
(0) 讚! | 赫莫萨西尼尔

作者: 磐石


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-04-07 12:24:00 評論於
It took 4 months to finally publish it, I won't play with bioinformatics anymore, almost broke my hands
(1) 讚! | 磐石

作者: 东京绮烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-31 11:01:21 評論於
Main research focus: Pan-cancer research; Monogenic; Sharing experience in bioinformatics research: Submitted manuscript in January, still stuck at step 4, what's going on?
(0) 讚! | 东京绮烟

作者: 削月金鑫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-14 19:20:47 評論於
At least it is SCI, we will get higher with more submissions, keep it up!
(0) 讚! | 削月金鑫

作者: Oliver Hazlitt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-12 14:28:30 評論於
The minor revision will be completed on December 18, 2023 and accepted on January 19, 2024. It is now online
(0) 讚! | Oliver Hazlitt

作者: Oliver Hazlitt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-12 11:41:39 評論於
The editors of this journal take language, description, grammar, and formatting very seriously and hope that it will continue to improve, so that we can also benefit
(0) 讚! | Oliver Hazlitt

作者: 东京绮烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-11 19:49:01 評論於
The submission webpage won't open
(0) 讚! | 东京绮烟

作者: 东京绮烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-11 09:52:40 評論於
I can't access the journal website recently
(0) 讚! | 东京绮烟

作者: 削月金鑫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-07 11:48:00 評論於
R3 has started, how are you doing now?
(0) 讚! | 削月金鑫

作者: 魔都绍懿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-05 13:53:05 評論於
It's indeed difficult
(0) 讚! | 魔都绍懿

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/22)

開始撰寫 [Translational Cancer Research] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*